Remiges Ventures
2022.09.26Remiges Ventures led the Series A round of finance for Kupando GmbH in Germany
2022.06.30Remiges selected as Certified VC by the AMED Drug Discovery Venture Ecosystem Enhancement Program
2022.06.06Luca Science, one of our portfolio companies in Japan, closed a $30.3M Series B round
2022.06.02Tranquis Therapeutics Announces Successful Completion of Phase 1 Clinical Trial of TQS-168
2022.03.08Digestome Therapeutics announced first patient enrolled in Phase1 clinical trial of DGX-001
2022.02.04Remiges Ventures co-led the Series Seed round of finance for Restore Vision, Inc. in Japan
